Laddar...
Efficacy and Safety of Canagliflozin in Kidney Transplant Patients
INTRODUCTION: There is no report of efficacy and safety of canagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor in post kidney transplant patients with diabetes. MATERIALS AND METHODS: A pilot study was undertaken in stable renal transplant recipients with preexisting diabetes or new on...
Sparad:
| I publikationen: | Indian J Nephrol |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Wolters Kluwer - Medknow
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668319/ https://ncbi.nlm.nih.gov/pubmed/31423063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijn.IJN_2_18 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|